CCO Independent Conference Coverage of CROI 2025: The Latest Updates in HIV *

This program summarizes key data and highlights from the 2025 Conference on Retroviruses and Opportunistic Infections (CROI).

Share

Program Content

18 Capsule Summaries

Activities

TB Prevention With 3HP vs 6H
3-Mo Rifapentine and Isoniazid vs 6-Mo Isoniazid TB Preventive Therapy in People Living With HIV in Western Kenya
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 12, 2025

Expires: September 11, 2025

MK8591A052 Phase III Trial of DOR and ISL
MK-8591A-052: Phase III Trial of Switch From BIC/FTC/TAF to DOR/ISL in People Living With Virologically Suppressed HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 12, 2025

Expires: September 11, 2025

MK8591A051
MK-8591A-051: Phase III Trial of Switch From Standard-of-Care ART to DOR/ISL in People Living With Virologically Suppressed HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 13, 2025

Expires: September 12, 2025

CARES 96 Wk
CARES: 96-Wk Efficacy and Safety of LA CAB + RPV in Sub-Saharan Africa
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 13, 2025

Expires: September 12, 2025

PILLAR
PILLAR: Efficacy and Persistence of Long-Acting Cabotegravir in Real-world Phase IV Trial of HIV PrEP
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 13, 2025

Expires: September 12, 2025

PURPOSE 1 Adolescent Women
PURPOSE 1: Lenacapavir PrEP in Adolescent Cisgender Women
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 14, 2025

Expires: September 13, 2025

Lenacapavir, Teropavimab, and Zinlirvimab
Phase II Study Results of Lenacapavir, Teropavimab, and Zinlirvimab for People Living with Virologically Suppressed HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 14, 2025

Expires: September 13, 2025

On Demand PrEP for Women
Utilizing PK/PD Modeling to Optimize On-Demand TDF/FTC PrEP Dosing for Women
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 14, 2025

Expires: September 13, 2025

DoxyPEP for STI Prevention
Doxycycline Postexposure Prophylaxis for STI Prevention in People on HIV PrEP Presenting for Sexual Health Visits
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 14, 2025

Expires: September 13, 2025

STOMP Tecovirimat
Phase III STOMP: Tecovirimat for the Treatment of Clade II Mpox
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 17, 2025

Expires: September 16, 2025

HPTN 094
HPTN 094: Mobile Unit Services Plus Peer Health Navigation vs Peer Health Navigation Alone for People Who Inject Drugs
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 17, 2025

Expires: September 16, 2025

BEe HIVe
BEe-HIVe: HepB-CpG HBV Vaccine Durability in People Living With HIV on ART ± Prior Vaccine History
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 17, 2025

Expires: September 16, 2025

HPTN 084 OLE
HPTN 084 OLE: HIV-1 RNA Screening in Women Receiving Long-Acting Cabotegravir for PrEP
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 17, 2025

Expires: September 16, 2025

Semaglutide in HIV
Semaglutide in People Living With HIV: Effect on Cognitive Function
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 17, 2025

Expires: September 16, 2025

HPTN 083 Case Series
HPTN 083 Case Series: Treatment Outcomes Among People Who Acquired HIV During LA CAB PrEP
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 18, 2025

Expires: September 17, 2025

RIO
RIO: Phase II Study Evaluating bNAbs for HIV Viremia Control
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 18, 2025

Expires: September 17, 2025

EMBRACE
EMBRACE: Phase IIb Study of VH3810109 (N6LS) in People Living With Virologically Suppressed HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 18, 2025

Expires: September 17, 2025

LAPTOP ART for Advanced HIV
LAPTOP: Integrase vs Protease Inhibitor–Based ART Regimens for Treatment-Naive People Living With Advanced HIV Disease
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 19, 2025

Expires: September 18, 2025

Activities

Spring HIV Conference Slides 2025
HIV Update: CCO Independent Conference Coverage of CROI 2025
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 24, 2025

Expires: March 23, 2026

Activities

HIV Update 1
HIV Update Webinar 1: CCO Independent Conference Coverage of CROI 2025
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 28, 2025

Expires: March 27, 2026

HIV Update 2
HIV Update Webinar 2: CCO Independent Conference Coverage of CROI 2025
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 31, 2025

Expires: March 30, 2026

Activities

Future of HIV at CROI
The Emerging Future of HIV Care: Highlights From CROI 2025
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: April 02, 2025

Expires: April 01, 2026

HIV and Aging at CROI
HIV and Aging at CROI 2025
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: April 02, 2025

Expires: April 01, 2026

Science in Times of Uncertainty
United We Stand: Promoting Science in Times of Uncertainty at CROI 2025
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 24, 2025

Expires: March 23, 2026

Real-World LA ART
Long-term, Real-world Safety and Efficacy of LA ART: Perspectives From Europe
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: April 02, 2025

Expires: April 01, 2026

Faculty

cover img faculity

Marta Boffito, MD, PhD, FRCP, MBA

Consultant Physician
Clinical Director - HIV, Sexual and Gender Health, Dermatology
Chelsea and Westminster Hospital MHS Foundation Trust
Imperial College London
London, United Kingdom

cover img faculity

Vincent Crisostomo

Patient Advocate
Director, Aging Services
San Francisco AIDS Foundation
San Francisco, California

cover img faculity

Joseph J. Eron, Jr., MD

Herman and Louise Smith Distinguished Professor of Medicine
Chief, Division of Infectious Disease
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology, Gillings School of Global Public Health
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, North Carolina

cover img faculity

Monica Gandhi, MD, MPH

Director, UCSF-Bay Area Center for AIDS Research (CFAR)
Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, “Ward 86” HIV Clinic, San Francisco General Hospital
University of California, San Francisco (UCSF)
San Francisco, California

cover img faculity

Beatriz Grinsztejn, MD, PhD

STD/AIDS Clinical Research Laboratory, Director
President of the International AIDS Society
Rio de Janeiro, Brazil

cover img faculity

Daniel R. Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Jean-Michel Molina, MD, PhD

Professor of Medicine
University of Paris Cité
Department of Infectious Diseases
Saint-Louis and Lariboisière Hospitals, APHP
Paris, France

cover img faculity

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Honorary Consultant Physician, Barts Health NHS Trust
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.